Malek Besbes Hlila, Habib Mosbah, Kaouther Majouli et al.158
The subfractions were analysed by RP-HPLC. The anti-coxsackie B 3 of SR 1
and SR 4 could be attributed to the phenolic compounds identified.
The obtained results might be considered sufficient to further studies for
the isolation of the active principles and to evaluate possible synergism among
components for their anti-coxsackie B 3 activity.
ACKNOWLEDGMENT
The authors are grateful to Dr Latifa REZK (Higher Institute of
Biotechnology of Monastir, University of Monastir, Tunisia) for helping with
English language.
REFERENCES
[1] Paige, M; Leigh, DIM. Dermatology. In: Kumar, P., Clark, M. (Eds.),
Clinical Medicine, 4th ed. W.B. Saunders., Italy: 1152– 1197; 1998.
[2] Melnick, JL; Enteroviruses: polioviruses, coxsackieviruses,
echoviruses, and newer enteroviruses. In: Fields, B.N., Knipe, D.M.
(Eds.), Virology. Raven Press., New York: 549–605; 1990.
[3] Wong, AH; Lau, CS; Cheng, PK; Ng, AY; Lim, WW. Coxsackievirus
B3-associated aseptic meningitis: An emerging infection in Hong Kong.
J. Med. Virol, 2011 83, 483-489.
[4] Ni, Z; Xiang, F; Huang, H; Wang, G; Li, F. Isolation and genetic
characterization of enterovirus in patients with febrile rash illness.
Biomedical Reports, 2015 3: 375-378.
[5] Barnard, DL. Current Status of Anti-Picornavirus Therapies. Curr.
Pharm. Des, 2006 12: 1379-1390. http://dx.doi.org.sci hub.org/
10.2174/138161206776361129.
[6] Brown, DJ; Dattner, AM. Phytotherapeutic approaches to common
dermatological conditions. Archives of Dermatology. 1998 134: 1401–
1404.
[7] Mantle, D; Gok, MA; Lennard, TW. Adverse and beneficial effects of
plant extracts in skin and skin disorders. Adverse Drug React Toxicol
Rev, 2001 20: 89–103.